Page last updated: 2024-09-04

n-(mercaptoacetyl)glycine and Coronary Restenosis

n-(mercaptoacetyl)glycine has been researched along with Coronary Restenosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hong, MK; Lee, HK; Lee, WW; Moon, DH; Oh, SJ; Park, SJ; Park, SW; Shin, DI1
Hong, MK; Jang, JS; Jeong, YH; Kim, JJ; Kim, SH; Kim, YH; Lee, CW; Lee, SW; Park, DW; Park, SJ; Park, SW; Yun, SC1

Other Studies

2 other study(ies) available for n-(mercaptoacetyl)glycine and Coronary Restenosis

ArticleYear
Automated preparation of 188Re-labeled radiopharmaceuticals for endovascular radiation therapy.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2003, Volume: 59, Issue:4

    Topics: Brachytherapy; Computer Systems; Computing Methodologies; Coronary Restenosis; Equipment Design; Equipment Failure Analysis; Glycine; Humans; Isotope Labeling; Pentetic Acid; Radioisotopes; Radiopharmaceuticals; Rhenium; Robotics; Systems Integration; Vascular Diseases

2003
Comparison of six-month angiographic and three-year outcomes after sirolimus-eluting stent implantation versus brachytherapy for bare metal in-stent restenosis.
    The American journal of cardiology, 2007, Aug-01, Volume: 100, Issue:3

    Topics: Brachytherapy; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Female; Glycine; Humans; Male; Middle Aged; Radioisotopes; Radiotherapy Dosage; Rhenium; Sirolimus; Stents; Treatment Outcome

2007